You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. House Republicans cancelled Friday’s votes, which my colleague Chelsea Cirruzzo jokingly called the “GTA 6 effect,” much to my total confusion. Send news tips and “single-player, third-person, action-adventure, open-world, sandbox video games” to [email protected] or John_Wilkerson.07 on Signal. MAHA PAC spends on itself MAHA PAC leaders blamed the election losses of the movement’s preferred candidates on the powerful forces supporting their rivals. The problem is the MAHA PAC didn’t spend much of its own fund to push back against those forces, Daniel Payne, Isabella Cueto, and Chelsea Cirruzzo report. Instead, filings show it spent big on its allies, boosters, and an affiliated nonprofit. Those investments often came at the expense of spending on political races, including for MAHA candidates in competitive districts. Read more about the investigation and how much the organization spent at Mastro’s Steakhouse D.C. Sanders’ Medicare for All plan Sen. Bernie Sanders (I-Vt.) is feeling optimistic about the first stage of his plan to vastly expand health coverage in the U.S. He predicted in a Wednesday press conference that Democrats will pass legislation lowering the Medicare eligibility age while President Trump is still in office, and that Trump might not veto it. In the first year of his plan, Congress would lower the Medicare eligibility age to 55; add dental, vision and hearing benefits; and guarantee free Medicaid coverage to children until age 19. And he pushed back on the assumption that Trump would veto such a bill. “I am not absolutely certain that Trump would not sign it,” he said. The health committee does not have jurisdiction over Medicare, but Sen. Ron Wyden (D-Ore.), who is expected to lead the committee that does have jurisdiction, said he is on board with Sanders’ plan. Rep. Hakeem Jeffries (D-N.Y.) also supports the “Medicare for More” and “Medikids” proposals, an indication that the party is quickly moving toward common ground on a health care agenda that averts divisions between its liberal and moderate wings. Sanders also gave insights into the health care investigations he might undertake, including of health secretary Robert F. Kennedy Jr. and the insurance and pharma industries. “Taking a hard look at the way the insurance industry runs, how they distort health care. Taking a hard look at the pharmaceutical industry as to why we pay by far the highest prices in the world for prescription drugs. Those are areas that need investigation,” he said. Why was Overton pulled? Who will run the FDA? Those are two of the seven burning questions Margaret Manto outlines for the FDA’s future after Heidi Overton’s nomination to lead the agency was pulled. One of the biggest mysteries is why the White House pulled her. Mysteries beget rumors, especially on Capitol Hill, and the biggest rumor is that President Trump’s new chief of staff Stephen Miller was behind it. Overton was supposedly not MAHA enough for Miller. The agency’s current acting commissioner, Kyle Diamantas, has reportedly declined to take the role permanently and wants out at the end of the year. Sen. Roger Marshall (R-Kansas), who lost his reelection bid, is rumored to be in the running. But it doesn’t look like he could get confirmed before Democrats take control of the Senate. Read more about who MAHA may rally around and what the turmoil means for an agency that regulates 20% of the U.S. economy. Rep. Carter wants the job But does the White House want the Georgia Republican as FDA commissioner? Buddy Carter is free. The pharmacist and advocate for reforming drug middlemen gave up his House seat to run for Senate. He came in third in the primary. And he wants the job. Carter said he told the White House he’s interested — the White House did not come to him. “I think they’ve got other plans,” Carter told STAT. Republicans surprised by withdrawal of Overton’s nomination Republicans said they were caught off guard by the Trump administration’s withdrawal of Overton on Tuesday night. “Before I went to bed, I thought we were voting on Overton,” committee member Sen. Lisa Murkowski (R-Alaska) told reporters as she exited the hearing room where senators had planned to vote on Overton. “So I haven’t given much thought to what the White House may do next, and maybe the White House hasn’t either,” she said. Sen. Bill Cassidy (R-La.), chair of the health committee with jurisdiction over the nomination, said Overton had sufficient support to win confirmation. He also said the White House told the press before telling him. Murkowski was among the holdouts, but she declined to say Wednesday morning whether she had planned to vote for Overton. “You are asking a theoretical question that doesn’t have a reasonable response to it,” she told reporters. Cassidy blocks Trump’s NSF nominee Cassidy also cancelled the Wednesday vote on Jim O’Neill, whom Trump nominated to lead the National Science Foundation, Daniel and Margaret report. O’Neill has held high-ranking posts at HHS and the Centers for Disease Control and Prevention. He would have led the NSF for six years if confirmed. But Cassidy said O’Neill didn’t have the support to advance. Read more about why Cassidy didn’t think he was up to the job. Preventive services panel reconvenes after long absence A little-known but influential panel that determines which preventive services insurance must cover will meet this week for the first time in more than a year, Chelsea reports. The membership of the U.S. Preventive Services Task Force was overhauled by Kennedy since it last met. Read more about what’s on the agenda and the backstory of its new membership. What we’re reading Updated health data privacy rule sets standards for sharing records with apps, STAT How Kennedy upended a group guiding health care for all Americans, The New York Times Scientists heralded a blue wave. But will they miss Susan Collins?, STAT NIH asks if Fauci secretly wrote paper that dismissed Covid lab leak theory, Politico
MAHA PAC’s steakhouse spend
Full Article
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.